07:43 AM EDT, 03/23/2026 (MT Newswires) -- Valneva (VALN) shares were 35% lower pre-bell Monday after the company and Pfizer (PFE) said their investigational vaccine candidate LB6V against outdoor Lyme disease reduced the rate of confirmed cases by 73.2% compared with placebo in a phase 3 clinical study.
AleAnna ( ANNA ) stock was down 16%, paring Friday's rally.
CF Industries ( CF ) shares were 8% lower following a muted session.